Company News
Kwality Pharmaceuticals Receives CDSCO Pembroluzimab Approval
Kwality Pharmaceuticals received CDSCO approval to manufacture preclinical pilot batches of biosimilar Pembroluzimab.
The approval marks the product's transition from research to preclinical developme
